Research Progress of Peripheral Immune Score Based on Blood Biomarkers and Its Application in Non-small Cell Lung Cancer / 现代检验医学杂志
Journal of Modern Laboratory Medicine
; (4): 192-198, 2024.
Article
de Zh
| WPRIM
| ID: wpr-1019940
Bibliothèque responsable:
WPRO
ABSTRACT
Lung cancer is the malignant tumor with the highest incidence and mortality among the Chinese.Tumor node metastasis(TNM)staging established by the American Joint Committee on Cancer(AJCC)and International Union Against Cancer(UICC)is a commonly used criterion,but it still has limitations in judging the prognosis of non-small cell lung cancer(NSCLC)patients.With the advantages of real-time and convenient sampling,the immune score based on peripheral blood biomarkers have the ability to predict prognosis and efficacy of NSCLC patients,which have been developed and validated in clinical studies.However,clinical impleruentation of peripheral immune scores is still not widely in NSCLC patients.Therefore,this study introduces and evaluates the 6 peripheral immune scores and reviews the reseach progress of them in the treatment of NSCLC.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Journal of Modern Laboratory Medicine
Année:
2024
Type:
Article